{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:17:43Z","timestamp":1788016663280,"version":"build-2784847793"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background and Purpose:<\/jats:title>\n                    <jats:p>\n                      Total skin electron beam therapy (TSEBT) is an important skin-directed radiotherapeutic procedure done in the treatment of cutaneous T-cell lymphomas, namely, mycosis fungoides (MF). This procedure is usually done at larger source-to-surface distances with the patient standing on a rotatory platform. As the patient has to stand in different positions without any rigid immobilization devices, there are chances that the total skin may not get uniformly irradiated which could lead to nonuniform dose distributions. Therefore, all the necessary arrangements should be made to evaluate the dose for different regions of the skin using suitable\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      dosimeters at the radiotherapy centers offering these treatments. This study aimed to evaluate the consistency between the delivered and planned doses\n                      <jats:italic toggle=\"yes\">in vivo<\/jats:italic>\n                      during TSEBT using Gafchromic EBT3 film dosimetry.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>\n                      The surface dose for the six MF patients treated for TSEBT at our hospital from 2018 to 2022 was measured and evaluated. 2 cm \u00d7 2 cm Gafchromic\n                      <jats:sup>\u00ae<\/jats:sup>\n                      EBT3 films were used to measure skin dose at reference body positions of clinical interest. All the patients were treated with the modified Stanford technique. The irradiated film strips were analyzed for the dose using the IMRT OmniPro software. The doses at respective positions were expressed as mean dose \u00b1 standard deviation and the deviation was calculated as the percentage of the prescribed dose.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      One hundred and fifty-four Gafchromic\n                      <jats:sup>\u00ae<\/jats:sup>\n                      EBT3 film strips irradiated on six TSEBT patients showed a maximum dose variation of 2.00 \u00b1 0.14 Gy, in the central body regions. The dose variation in the peripheral areas such as hands and ears was larger. A variation of 2 \u00b1 0.32 Gy was observed on the hands and ears. The uniformity of the dose delivered to maximum body parts was within \u22127% and +16% for the peripheral areas like hands. The American Association of Physicists in Medicine recommends a dose uniformity of 8% and 4% in the vertical and horizontal patient plane for direct incident beam; however, for oblique incidences like in the modified Stanford technique, the dose variation is about 15%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      <jats:italic toggle=\"yes\">In vivo<\/jats:italic>\n                      dosimetry using Gafchromic EBT3 film dosimetry for TSEBT yields objective data to find the under or overdose regions. That can be useful to provide quality treatment, especially when treatments tend to be as complex as TSEBT.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jmp.jmp_72_22","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T02:42:19Z","timestamp":1673318539000},"page":"362-366","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["In vivo Dosimetry for Dose Verification of Total Skin Electron Beam Therapy Using Gafchromic\u00ae EBT3 Film Dosimetry"],"prefix":"10.4103","volume":"47","author":[{"given":"Misba Hamid","family":"Baba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoy Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaqul Qamar","family":"Wani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-7-20240906","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.hoc.2016.11.008","article-title":"Mycosis Fungoides and Sezary Syndrome","volume":"31","author":"Foss","year":"2017","journal-title":"Hematol Oncol Clin"},{"key":"R3-7-20240906","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: A population-based study of 3884 cases","volume":"113","author":"Bradford","year":"2009","journal-title":"Blood"},{"key":"R4-7-20240906","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2010.32.0630","article-title":"Clinical end points and response criteria in mycosis fungoides and S\u00e9zary syndrome: A consensus statement of the International society for cutaneous lymphomas, the United States cutaneous lymphoma consortium, and the cutaneous lymphoma task force of the European organisation for research and treatment of cancer","volume":"29","author":"Olsen","year":"2011","journal-title":"J Clin Oncol"},{"key":"R5-7-20240906","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000475634","article-title":"Total skin electron beam therapy as part of multimodal treatment strategies for primary cutaneous T-Cell lymphoma","volume":"40","author":"Elsayad","year":"2017","journal-title":"Oncol Res Treat"},{"key":"R6-7-20240906","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejca.2017.02.027","article-title":"European organisation for research and treatment of cancer consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome \u2013 Update 2017","volume":"77","author":"Trautinger","year":"2017","journal-title":"Eur J Cancer"},{"key":"R7-7-20240906","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijrobp.2015.01.008","article-title":"Modern radiation therapy for primary cutaneous lymphomas: Field and dose guidelines from the International lymphoma radiation oncology group","volume":"92","author":"Specht","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R8-7-20240906","doi-asserted-by":"crossref","first-page":"100698","DOI":"10.1016\/j.adro.2021.100698","article-title":"Recumbent total skin electron beam therapy","volume":"6","author":"Ackerson","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"R9-7-20240906","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clml.2018.11.015","article-title":"Total skin electron beam therapy for mycosis fungoides revisited with adjuvant systemic therapy","volume":"19","author":"Rivers","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R11-7-20240906","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1118\/1.3442301","article-title":"Total skin electron therapy (TSET): A reimplementation using radiochromic films and IAEA TRS-398 code of practice","volume":"37","author":"Schiapparelli","year":"2010","journal-title":"Med Phys"},{"key":"R12-7-20240906","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejmp.2012.10.001","article-title":"Evaluation of Gafchromic\u00ae EBT3 films characteristics in therapy photon, electron and proton beams","volume":"29","author":"Sorriaux","year":"2013","journal-title":"Phys Med"},{"key":"R13-7-20240906","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1118\/1.3030951","article-title":"In vivo verification of superficial dose for head and neck treatments using intensity-modulated techniques","volume":"36","author":"Qi","year":"2009","journal-title":"Med Phys"},{"key":"R14-7-20240906","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejmp.2020.11.019","article-title":"Optimized method for in vivo dosimetry with small films in pelvic IOERT for rectal cancer","volume":"81","author":"Santos","year":"2021","journal-title":"Phys Med"},{"key":"R15-7-20240906","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4103\/0971-6203.116372","article-title":"A study on rectal dose measurement in phantom and in vivo using Gafchromic EBT3 film in IMRT and CyberKnife treatments of carcinoma of prostate","volume":"38","author":"Ganapathy","year":"2013","journal-title":"J Med Phys"},{"key":"R16-7-20240906","doi-asserted-by":"crossref","first-page":"012020","DOI":"10.1088\/1742-6596\/851\/1\/012020","article-title":"Radiotherapy dose verification on a customised head and neck perspex phantom","volume":"851","author":"Eng","year":"2017","journal-title":"J Phys Conf Ser"},{"key":"R17-7-20240906","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ejmp.2012.04.004","article-title":"Dose to the skin in helical tomotherapy: Results of in vivo measurements with radiochromic films","volume":"29","author":"Avanzo","year":"2013","journal-title":"Phys Med"},{"key":"R19-7-20240906","first-page":"170","article-title":"In-vivo skin dose measurement using gafchromic EBT3 film dosimetry in the radiation therapy of Head and Neck cancers: 2DRT versus IMRT","volume":"15","author":"Baba","year":"2022","journal-title":"J Radiat Res Appl Sci"},{"key":"R20-7-20240906","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0360-3016(88)90306-9","article-title":"Total skin electron irradiation for mycosis fungoides: Relationship between acute toxicities and measured dose at different anatomic sites","volume":"15","author":"Desai","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R21-7-20240906","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0360-3016(95)00161-Q","article-title":"Evaluation of dose variation during total skin electron irradiation using thermoluminescent dosimeters","volume":"33","author":"Weaver","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R22-7-20240906","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0360-3016(97)00585-3","article-title":"Utilization of thermoluminescent dosimetry in total skin electron beam radiotherapy of mycosis fungoides","volume":"40","author":"Antolak","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R23-7-20240906","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.rpor.2013.07.011","article-title":"Review of the results of the in vivo dosimetry during total skin electron beam therapy","volume":"19","author":"Guidi","year":"2014","journal-title":"Rep Pract Oncol Radiother"},{"key":"R26-7-20240906","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejmp.2007.03.003","article-title":"In vivo EBT radiochromic film dosimetry of electron beam for total skin electron therapy (TSET)","volume":"23","author":"Bufacchi","year":"2007","journal-title":"Phys Med"},{"key":"R27-7-20240906","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.1118\/1.4767770","article-title":"Dose-response curve of EBT, EBT2, and EBT3 radiochromic films to synchrotron-produced monochromatic x-ray beams","volume":"39","author":"Brown","year":"2012","journal-title":"Med Phys"}],"container-title":["Journal of Medical Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jmp.jmp_72_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:32:22Z","timestamp":1787758342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jmp.jmp_72_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jmp.jmp_72_22","relation":{},"ISSN":["0971-6203"],"issn-type":[{"value":"0971-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}